Manappuram Finance slumps over 14% on weak Q3 results

Manappuram Finance slumps over 14% on weak Q3 results

AgenciesUpdated: Tuesday, February 15, 2022, 01:51 PM IST
article-image
On BSE, the shares of Manappuram Finance fell 14.68 percent to its 52-week low value of Rs 122./ Representative image | File photo

Shares of Manappuram Finance on Tuesday dropped as much as 14 per cent after the company reported a nearly 46 per cent decline in consolidated net profit at Rs 261 crore for the quarter ended December 2021.

On BSE, the shares fell 14.68 per cent to its 52-week low value of Rs 122.

On NSE, the shares were trading at its 52-week low value of Rs 123.75, sliding 13.4 per cent over the previous close.

The non-banking finance company (NBFC) had posted a net profit of Rs 483 crore in the corresponding quarter a year ago.

Total income during the October-December period of 2021-22 was down at Rs 1,506.85 crore, as against Rs 1,650 crore in the same period of 2020-21, Manappuram Finance said in a regulatory filing on Monday.

RECENT STORIES

Gujarat's Handloom & Handicraft Sector Reports Strong Revival, Recording Sales Worth ₹17.5 Crore

Gujarat's Handloom & Handicraft Sector Reports Strong Revival, Recording Sales Worth ₹17.5 Crore

Price Of 24-Carat Gold Surges By ₹4,694 Over The Week, Supported By Safe Haven Buying & Dollar...

Price Of 24-Carat Gold Surges By ₹4,694 Over The Week, Supported By Safe Haven Buying & Dollar...

ED Arrests Ocean Seven Buildtech's Managing Director After Conducting Searches At Nine Locations...

ED Arrests Ocean Seven Buildtech's Managing Director After Conducting Searches At Nine Locations...

Realty Company Anant Raj Will Invest ₹4,500 Crore In Andhra Pradesh To Set Up Data Centres As Part...

Realty Company Anant Raj Will Invest ₹4,500 Crore In Andhra Pradesh To Set Up Data Centres As Part...

World-Famous Diamonds From Panna, Madhya Pradesh, Awarded The Prestigious Geographical Indication...

World-Famous Diamonds From Panna, Madhya Pradesh, Awarded The Prestigious Geographical Indication...